SEAN O'MORROW: Open Payments
NPI 1942065669 · GRAND BLANC, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$360 in 13 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $360
Food & beverage: $360
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 3 | $146 |
| E.R. Squibb & Sons, L.L.C. | 4 | $85 |
| Alkermes, Inc. | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
| Lundbeck LLC | 1 | $16 |
Products named: Auvelity, COBENFY, REXULTI, ARISTADA, Sunosi, AUSTEDO XR, CAPLYTA, INGREZZA.
Industry payments across MI — which companies pay providers there.
